Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Potassium channel KIR4.1 as an immune target in multiple sclerosis.

Srivastava R, Aslam M, Kalluri SR, Schirmer L, Buck D, Tackenberg B, Rothhammer V, Chan A, Gold R, Berthele A, Bennett JL, Korn T, Hemmer B.

N Engl J Med. 2012 Jul 12;367(2):115-23. doi: 10.1056/NEJMoa1110740.

2.

Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.

Kraus V, Srivastava R, Kalluri SR, Seidel U, Schuelke M, Schimmel M, Rostasy K, Leiz S, Hosie S, Grummel V, Hemmer B.

Neurology. 2014 Feb 11;82(6):470-3. doi: 10.1212/WNL.0000000000000097. Epub 2014 Jan 10.

PMID:
24415573
3.

Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.

Brickshawana A, Hinson SR, Romero MF, Lucchinetti CF, Guo Y, Buttmann M, McKeon A, Pittock SJ, Chang MH, Chen AP, Kryzer TJ, Fryer JP, Jenkins SM, Cabre P, Lennon VA.

Lancet Neurol. 2014 Aug;13(8):795-806. doi: 10.1016/S1474-4422(14)70141-3. Epub 2014 Jul 6.

4.

Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.

Schirmer L, Srivastava R, Kalluri SR, Böttinger S, Herwerth M, Carassiti D, Srivastava B, Gempt J, Schlegel J, Kuhlmann T, Korn T, Reynolds R, Hemmer B.

Ann Neurol. 2014 Jun;75(6):810-28. doi: 10.1002/ana.24168. Epub 2014 May 21.

PMID:
24777949
5.

Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.

Nerrant E, Salsac C, Charif M, Ayrignac X, Carra-Dalliere C, Castelnovo G, Goulabchand R, Tisseyre J, Raoul C, Eliaou JF, Labauge P, Vincent T.

Mult Scler. 2014 Nov;20(13):1699-703. doi: 10.1177/1352458514531086. Epub 2014 Apr 22.

PMID:
24756568
6.

Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.

Nakajima M, Kawamura T, Tokui R, Furuta K, Sugino M, Nakanishi M, Okuyama S, Furukawa Y.

Brain Res. 2013 Nov 6;1537:340-9. doi: 10.1016/j.brainres.2013.09.024. Epub 2013 Sep 23.

PMID:
24070676
7.
8.

Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.

Chastre A, Hafler DA, O'Connor KC.

N Engl J Med. 2016 Apr 14;374(15):1495-6. doi: 10.1056/NEJMc1513302. No abstract available.

9.

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.

Malyavantham K, Weinstock-Guttman B, Suresh L, Zivadinov R, Shanahan T, Badgett D, Ramanathan M.

PLoS One. 2015 Jun 11;10(6):e0129503. doi: 10.1371/journal.pone.0129503. eCollection 2015.

10.

Increased anti-KIR4.1 antibodies in multiple sclerosis: could it be a marker of disease relapse?

Brill L, Goldberg L, Karni A, Petrou P, Abramsky O, Ovadia H, Ben-Hur T, Karussis D, Vaknin-Dembinsky A.

Mult Scler. 2015 Apr;21(5):572-9. doi: 10.1177/1352458514551779. Epub 2014 Nov 12.

PMID:
25392324
11.

Multiple Sclerosis and Antibodies against KIR4.1.

Pröbstel AK, Kuhle J, Lecourt AC, Vock I, Sanderson NS, Kappos L, Derfuss T.

N Engl J Med. 2016 Apr 14;374(15):1496-8. doi: 10.1056/NEJMc1507131. No abstract available.

12.

Detection of potassium channel KIR4.1 antibodies in Multiple Sclerosis patients.

Marnetto F, Valentino P, Caldano M, Bertolotto A.

J Immunol Methods. 2017 Jun;445:53-58. doi: 10.1016/j.jim.2017.03.008. Epub 2017 Mar 12.

PMID:
28300540
13.
14.

Antibodies to potassium channels in multiple sclerosis.

Cross AH, Waubant E.

N Engl J Med. 2012 Jul 12;367(2):172-4. doi: 10.1056/NEJMe1204118. No abstract available.

PMID:
22784120
15.

Anti-KIR4.1 Antibodies in Chinese Patients with Central Nervous System Inflammatory Demyelinating Disorders.

Zhong R, Liang J, Tao A, Wu L, Yang X, Xu H, Huang Q, Zhuang S, Long Y, Gao C.

Neuroimmunomodulation. 2016;23(5-6):295-300. doi: 10.1159/000452764. Epub 2017 Apr 8.

PMID:
28391264
16.

Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies--conflicting results?

Hemmer B.

Mult Scler. 2015 Apr;21(5):537-9. doi: 10.1177/1352458514564493. Epub 2015 Jan 12. No abstract available.

PMID:
25583849
17.

The potassium channel Kir4.1 associates with the dystrophin-glycoprotein complex via alpha-syntrophin in glia.

Connors NC, Adams ME, Froehner SC, Kofuji P.

J Biol Chem. 2004 Jul 2;279(27):28387-92. Epub 2004 Apr 21.

18.

Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.

Navas-Madroñal M, Valero-Mut A, Martínez-Zapata MJ, Simón-Talero MJ, Figueroa S, Vidal-Fernández N, López-Góngora M, Escartín A, Querol L.

PLoS One. 2017 Apr 17;12(4):e0175538. doi: 10.1371/journal.pone.0175538. eCollection 2017.

19.

Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy.

Heuser K, Eid T, Lauritzen F, Thoren AE, Vindedal GF, Taubøll E, Gjerstad L, Spencer DD, Ottersen OP, Nagelhus EA, de Lanerolle NC.

J Neuropathol Exp Neurol. 2012 Sep;71(9):814-25. doi: 10.1097/NEN.0b013e318267b5af.

20.

KIR4.1: K+ Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis.

Gu C.

Front Mol Neurosci. 2016 Sep 27;9:90. eCollection 2016. Review.

Supplemental Content

Support Center